Morten Sogaard
Company: Astellas Innovation Management
Job title: President, Gene Therapy Research & Technical Operations
Seminars:
Panel Discussion: Breaking Boundaries: Navigating the Shift from Rare to Common Diseases in Gene Therapy 1:30 pm
• Exploring the unique challenges and benefits of expanding gene therapy into more prevalent conditions, including patient access, cost, and treatment scalability • Evaluating the feasibility of widespread gene therapy applications in common diseases by 2025, along with realistic goals and potential hurdles • Essential factors for successful translation, including regulatory preparedness, CMC adaptation, and…Read more
day: Focus Day
Opening Remarks & Group Introductions 9:00 am
day: Focus Day
Effective Strategies for Transitioning from Rare to Common Diseases to Expand Gene Therapy Horizons 9:30 am
• Analysis of the challenges and opportunities in scaling gene therapy technologies from rare to common diseases, including adjustments in clinical trial design and patient populations • Examination of strategies to reduce production costs and enhance cost-effectiveness while maintaining high-quality standards for larger patient populations • Insights into the regulatory hurdles and market strategies required…Read more
day: Focus Day